Archangels
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
Earth Blox secures £6m in funding led by PXN Ventures to turn natural risk into financial insights
Earth Blox is a technology platform that helps organisations understand how nature loss and climate hazards affect financial performance. It combines satellite, environmental and portfolio data to provide analysis for banks, businesses and other institutions.
BIOCAPTIVA secures £1.6m in funding led by Archangels for magnetic bead tech that prepares blood samples for liquid biopsy
BIOCAPTIVA develops magnetic bead technology that prepares blood samples for liquid biopsy testing. Its platform captures cell-free DNA directly from whole blood to improve how samples are processed for cancer research and diagnostics.
1nhaler secures £1.5m in further seed funding led by Archangels to advance its pop-up cardboard inhaler
1nhaler designs a single dose dry powder inhaler made primarily from cardboard that folds flat for portability, offering a simpler and more sustainable alternative to conventional plastic inhalers.
CSignum secures £6m Series A led by Archangels and Par Equity to scale underwater wireless IoT comms
CSignum develops wireless communication technology that transmits data from underwater and underground sensors, enabling real-time monitoring in environments where conventional signals cannot operate.
Neuranics raises £6m seed led by Blackfinch Ventures to commercialise magnetic sensing for XR and wearables
Neuranics develops ultra-sensitive magnetic sensors that enable contactless monitoring of muscle and heart signals, supporting gesture recognition and biometric tracking in wearables and XR devices.
Cytomos secures £5m led by Archangels to scale up production of cell-analysis technology
Cytomos builds scalable cell analysis technology that measures intrinsic cellular properties in real time, helping biopharma companies accelerate drug discovery and manufacturing decisions.
More venture news
- 9 Sept 2026
ViaNautisViaNautis secures investment from SCI Ventures to deliver non-viral genetic medicines to cells at spinal cord injury sites
EquityLife Sciences - 9 Sept 2026
CloudNCCloudNC lands £15m in funding led by Nimble Ventures to reduce bottlenecks in precision machining
EquityIndustrial - 9 Sept 2026
KVectorKVector raises £3.8m in funding from VCs to develop low-power radar antennas
EquityTelecoms
